Arcus Biosciences Inc
(NYSE:RCUS)
$
15.27
-0.56 (-3.54%)
Market Cap: 1.40 Bil
Enterprise Value: 417.63 Mil
PE Ratio: 0
PB Ratio: 2.47
GF Score: 79/100 Arcus Biosciences Inc at Barclays Global Healthcare Conference Transcript
Mar 17, 2022 / 02:15PM GMT
Release Date Price:
$34.5
(+3.39%)
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst
So first and foremost, it's good to see everybody back in person again after 2-year live in person. Thanks for all your support and enthusiasm for attending Barclays Biotech Conference in Miami for both investors and management team from Arcus. So up on stage, I've got Terry Rosen, CEO; and Jennifer Jarrett, COO.
Jennifer Jarrett
Arcus Biosciences, Inc. - COO & Director
Today. So today (inaudible).
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst
Today, you're the COO. Perfect. So thanks so much. And we're trying to keep this informal as possible.
Questions & Answers
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst
I think the first question for me for kind of Arcu's upcoming sort of massive data set in the second half. Before that, we make it Roche data as well in small cell lung cancer and 3 other indications. How do you
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot